Fatty Acid Diets for Aging
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different types of fatty acids in diets affect brain function in healthy adults aged 65-75. Participants will follow two experimental diets: one high in palmitic acid, common in North American diets, and another high in oleic acid, found in Mediterranean diets (also known as the High Oleic Acid Diet). Each diet lasts for one week, with a balanced low-fat diet in between. Eligible participants are those with normal mental function who are generally healthy and do not have serious health conditions or dietary restrictions. As an unphased trial, this study allows participants to contribute to valuable research on diet and brain health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on certain medications for cognitive or behavioral issues, hormone replacement therapy, or treatments for certain health conditions like Type 2 Diabetes (unless it's metformin).
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the High Oleic Acid (HOA) diet often links to good health. Studies indicate that diets rich in oleic acid, a key component of the Mediterranean diet, can lower inflammation markers like Interleukin-6 (IL-6). This suggests the HOA diet could benefit overall health and well-being.
In contrast, the High Palmitic Acid (HPA) diet has shown mixed results. Some studies suggest that reducing palmitic acid can improve brain function and decrease inflammation in older adults. However, diets high in palmitic acid have been linked to increased levels of certain proteins associated with brain changes.
Both diets have been studied in healthy older adults, and no serious safety concerns have been reported. However, the HOA diet generally links to better health outcomes compared to the HPA diet. While both diets are considered safe, the HOA diet might offer more health benefits.12345Why are researchers excited about this trial?
Researchers are excited about the Fatty Acid Diets for Aging trial because it's exploring how different types of fats in our diets might impact aging. Unlike traditional dietary recommendations that often focus on calorie counting or macronutrient ratios, this trial specifically examines the effects of consuming high oleic acid, a monounsaturated fat prevalent in the Mediterranean diet, and high palmitic acid, a saturated fat common in the American diet. These diets could offer new insights into how specific fats influence aging processes, potentially leading to more tailored dietary guidelines that promote healthier aging. The trial could reveal whether the Mediterranean diet's heart-healthy fats offer distinct benefits over typical saturated fats found in many processed foods.
What evidence suggests that this trial's diets could be effective for brain functioning in aging adults?
This trial will compare the effects of two different diets on aging: the High Oleic Acid Diet (HOA) and the High Palmitic Acid Diet (HPA). Research has shown that the Mediterranean diet, similar to the HOA diet, is high in oleic acid and links to better health. Studies indicate that people who closely follow this diet tend to live longer and have a lower risk of heart disease. Olive oil, a main source of oleic acid, is known for its anti-inflammatory properties and cell protection, which may contribute to longevity.
In contrast, the HPA diet, similar to diets high in palmitic acid often found in the North American diet, can negatively affect brain function and increase inflammation. Research suggests that reducing palmitic acid intake can decrease inflammation and improve brain function in older adults. Overall, the Mediterranean diet, rich in oleic acid, offers promising benefits for aging and brain health.14678Who Is on the Research Team?
JUlie A Dumas, Ph.D.
Principal Investigator
University of Vermont
Craig L Kien, MD, PhD
Principal Investigator
University of Vermont
Are You a Good Fit for This Trial?
This trial is for healthy older adults aged 65-75 who want to participate in a study on how different fats in the diet affect brain function. Participants will follow strict diets provided by the research team and be closely monitored.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Control Diet
Participants follow a low-fat control diet to balance monounsaturated and saturated fatty acids
Experimental Diets
Participants follow two experimental diets in a random order: one with a high PA/OA ratio and one with a low PA/OA ratio
Follow-up
Participants are monitored for changes in working memory performance and brain activation
What Are the Treatments Tested in This Trial?
Interventions
- High Oleic Acid Diet
- High Palmitic Acid Diet
Trial Overview
The study tests two diets: one high in palmitic acid, like a typical North American diet, and another high in oleic acid, similar to the Mediterranean Diet. Each participant tries both for one week with a low-fat control diet before each test period.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will ingest the HPA diet for one week. The saturated fatty acid will be high in palmitic acid which is the most prevalent saturated fatty acid in the American diet. The HPA diet will be proceeded by a one week controlled diet were the fat content is balanced between monounsaturated and saturated fatty acids.
Participants will ingest the HOA diet for one week. The monounsaturated fatty acid will be high in oleic acid which is the most prevalent monounsaturated fatty acid in the Mediterranean diet. The HOA diet will be proceeded by a one week controlled diet were the fat content is balanced between monounsaturated and saturated fatty acids.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Vermont
Lead Sponsor
Published Research Related to This Trial
Citations
Mediterranean diet component oleic acid decreases ...
This study investigates whether nutritional intervention mitigates age-associated systemic impact of oral infection with PD key pathogen Porphyromonas ...
Mediterranean diet and health status: Active ingredients ...
A large body of observational and experimental evidence suggests that higher adherence to the MedDiet is associated with lower risk of mortality, cardiovascular ...
3.
annexpublishers.com
annexpublishers.com/articles/JNH/12102-Olive-Oil-and-Longevity-A-Review-of-Evidence-Linking.pdfOlive Oil and Longevity: A Review of Evidence Linking ...
Olive oil, especially EVOO, is linked to reduced mortality and age-related diseases, with antioxidant, anti-inflammatory, and cardioprotective ...
Olive Oil and the Hallmarks of Aging - PMC - PubMed Central
Olive oil targets the hallmarks of aging could explain the improvement of health, reduced risk of aging-associated diseases, and increased longevity.
The Mediterranean Diet and Cardiovascular Health
The available evidence is large, strong, and consistent. Better conformity with the traditional MedDiet is associated with better cardiovascular health outcomes ...
The effects of the mediterranean diet supplemented with ...
We revealed that following an enriched MED with olive oils can reduce Interleukin-6 (IL-6) (SMD: − 1.85; 95% CI: -3.69 to -0.01, I2: 99.29%) and ...
Cardiovascular, Metabolic and Endocrine, Cancer ...
Olive oil is proven to be a healthy dietary option for Type 2 diabetes and cardiovascular disease populations, a superior topical application ...
Mediterranean Diet and Quality of Life in Adults
Adherence to the Mediterranean diet provides significant benefits in preventing and managing various chronic diseases commonly associated with aging ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.